<code id='CDDE5DC5ED'></code><style id='CDDE5DC5ED'></style>
    • <acronym id='CDDE5DC5ED'></acronym>
      <center id='CDDE5DC5ED'><center id='CDDE5DC5ED'><tfoot id='CDDE5DC5ED'></tfoot></center><abbr id='CDDE5DC5ED'><dir id='CDDE5DC5ED'><tfoot id='CDDE5DC5ED'></tfoot><noframes id='CDDE5DC5ED'>

    • <optgroup id='CDDE5DC5ED'><strike id='CDDE5DC5ED'><sup id='CDDE5DC5ED'></sup></strike><code id='CDDE5DC5ED'></code></optgroup>
        1. <b id='CDDE5DC5ED'><label id='CDDE5DC5ED'><select id='CDDE5DC5ED'><dt id='CDDE5DC5ED'><span id='CDDE5DC5ED'></span></dt></select></label></b><u id='CDDE5DC5ED'></u>
          <i id='CDDE5DC5ED'><strike id='CDDE5DC5ED'><tt id='CDDE5DC5ED'><pre id='CDDE5DC5ED'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:12571
          A phone screen displays the webpage of Medicare.gov — coverage from STAT
          Adobe

          Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

          But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

          advertisement

          The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          It's time to take a new tack for treating Alzheimer's
          It's time to take a new tack for treating Alzheimer's

          AdobeIfinsanityisdoingthesamethingoverandoveragainbutexpectingdifferentresults,thenthelastdecadeorso

          read more
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

          FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

          read more

          How Brent Saunders' Allergan experiment failed

          Allergan,DomSmith/STATItwasn’tsupposedtoworkoutthiswayforBrentSaunders.Fouryearsago,Saunderswasthewh